Product
DR-0201
2 clinical trials
2 indications
Indication
B-cell Non-Hodgkin LymphomaIndication
Healthy Adult VolunteersClinical trial
A Multicenter, Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Multiple Ascending Doses in Patients With Relapsed/Refractory B Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A First-in-Human Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Single Ascending Dose in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-06-01